Clinical profile of the novel antidepressant bupropion
Stern, W.C.; Harto-Truax, N.; Rogers, J.; Miller, L.
Advances in Biochemical Psychopharmacology 32: 21-34
1982
ISSN/ISBN: 0065-2229 PMID: 6807060 Document Number: 183318
Document emailed within 1 workday
Related Documents
Halaris, A.E.; Stern, W.; Harto-Truax, N. 1981: Clinical efficacy of the new antidepressant bupropion (Wellbutrin) Psychopharmacology Bulletin 17(1): 140-142Clay, T.H.; Gualtieri, C.T.; Evans, R.W.; Gullion, C.M. 1988: Clinical and neuropsychological effects of the novel antidepressant bupropion Psychopharmacology Bulletin 24(1): 143-148
Stern, W.C.; Harto-Truax, N. 1980: Two multicenter studies of the antidepressant effects of bupropion HCl versus placebo Psychopharmacology Bulletin 16(3): 43-46
El-Dakhakhny, M.; Abdel el-Latif, H.A.; Ammon, H.P. 1996: Different effects of the antidepressant drugs imipramine, maprotiline and bupropion on insulin secretion from mouse pancreatic islets Arzneimittel-Forschung 46(7): 667-669
Maj, J. 1987: Pharmacological profile and mechanism of action of antidepressant drugs Acta Physiologica Polonica 38(4): 289-301
Hache, J.; Duchene-Marullaz, P.; Streichenberger, G. 1974: Pharmacological profile of a new non tricyclic antidepressant: oxaflozane (1,766 Cerm) Therapie 29(1): 81-93
Eguchi, J.; Inomata, Y.; Yuasa, T.; Egawa, M.; Saito, K. 1997: Pharmacological profile of the novel antidepressant 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno-[2,3-d]pyrimidine monohydrate hydrochloride Arzneimittel-Forschung 47(12): 1337-1347
Ferry, L.; Johnston, J.A. 2003: Efficacy and safety of bupropion SR for smoking cessation: data from clinical trials and five years of postmarketing experience International Journal of Clinical Practice 57(3): 224-230
McCombs, J.S.; Nichol, M.B.; Stimmel, G.L.; Sclar, D.A.; Beasley, C.M.; Gross, L.S. 1990: The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population Journal of Clinical Psychiatry 51 Suppl: 60-69; Discussion: 70-71
Monuteaux, M.C.; Spencer, T.J.; Faraone, S.V.; Wilson, A.M.; Biederman, J. 2007: A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder Journal of Clinical Psychiatry 68(7): 1094-1101
Hughes, S; Wilkinson, R; Humphreys, D; Macmillan, T; Rae, I D. 2001: Profile 1 - The Global Compact: Promoting Corporate Responsibility? Profile 2 - The Creation of the United Nations Forum on Forests Profile 3 - The rBST Ban - A Taste of What's to Come for GM Foods? Profile 4 - Managing Waste Organochlorine Chemicals in Australia Environmental Politics 10(1): 155-177
Wilson, J.E.; Chu, C.C.; Williams, S.E.; Ruedrich, S.L. 1984: Clinical use of antidepressant medications Nebraska Medical Journal 69(5): 148-153
Jarvis, M.R. 1991: Clinical pharmacokinetics of tricyclic antidepressant overdose Psychopharmacology Bulletin 27(4): 541-550
Lyndon, B.; Rowe, L.; Fraser, A.; Efron, D.; Walter, G.; Wilson, I.; Newman, L.; Silove, N. 2005: Clinical guidance on the use of antidepressant medications in children and adolescents Australian Family Physician 34(9): 777-778
Itil, T.M.; Cora, R.; Hsu, W.; Gig, E.; Saletu, B. 1972: Clinical, toxicological and electroencephalographical effects of a new tricyclic antidepressant, OI-77 Arzneimittel-Forschung 22(12): 2063-2066
Sinnott, C.; Morris, M. 2013: Agomelatine: clinical experience and adherence to EMA recommendations for a novel antidepressant Irish Medical Journal 106(2): 52-54
Mago, R.; Thase, M.E.; Rovner, B.W. 2013: Antidepressant-induced excessive sweating: clinical features and treatment with terazosin Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 25(3): 186-192
Küfferle, B.; Grünberger, J. 1982: Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant Advances in Biochemical Psychopharmacology 32: 175-180
Sjöqvist, F. 1980: The measurement of psychotherapeutic drug concentrations in biological fluids: utility in clinical trials and practice. Overview by drug classes--clinical monitoring of tricyclic antidepressant plasma concentrations Psychopharmacology Bulletin 16(3): 21-25
Tanaka, T.; Inoue, T.; Suzuki, K.; Kitaichi, Y.; Masui, T.; Denda, K.; Koyama, T. 2007: Clinical relevance of antidepressant-induced activation syndrome: from a perspective of bipolar spectrum disorder Seishin Shinkeigaku Zasshi 109(8): 730-742